HIV-1 capsid: the multifaceted key player in HIV-1 infection

Campbell, Edward M., Hope, Thomas J.·2015·Nature Reviews Microbiology

Cited by (427)

Items 201–300 of 427

  1. Discovery of anti-cell migration activity of an anti-HIV heterocyclic compound by identification of its binding protein hnRNP M
    Masahiro Kamo, Miu Ito, Tsugumasa Toma, Haruna Gotoh, Rie Shimozono, Riko Nakagawa, Ryoko Koga, Kazuaki Monde, Hiroshi Tateishi, Shogo Misumi et al. · 2021 · Bioorganic Chemistry
  2. Self-assembled cell-scale containers made from DNA origami membranes
    Christoph Karfusehr, Markus Eder, Hao Yuan Yang, Brice Beinsteiner, Marion Jasnin, Friedrich Christian Simmel · 2025 · Nature Materials
  3. Modeling the dynamics and kinetics of HIV-1 Gag during viral assembly
    Michael D. Tomasini, Daniel S. Johnson, Joshua S. Mincer, Sanford M. Simon · 2018 · PLoS ONE
  4. Sub-dominant principal components inform new vaccine targets for HIV Gag
    Syed Faraz Ahmed, Ahmed Abdul Quadeer, David Morales‐Jiménez, Matthew R. McKay · 2019 · Bioinformatics
  5. HIV-1 Replication Benefits from the RNA Epitranscriptomic Code
    Weili Kong, Efraín E. Rivera-Serrano, Jason A. Neidleman, Jian Kang Zhu · 2019 · Journal of Molecular Biology
  6. Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host
    Fabian Schmidt, Brandon F. Keele, Gregory Q. Del Prete, Dennis Voronin, Christine M. Fennessey, Steven J. Soll, Melissa Kane, Alice Raymond, Robert James Gifford, Vineet N. KewalRamani et al. · 2019 · Proceedings of the National Academy of Sciences
  7. HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton
    Romina Cabrera-Rodríguez, Silvia Pérez-Yanes, Iria Lorenzo-Sánchez, Rodrigo Trujillo‐González, Judith Estévez‐Herrera, Jonay García-Luis, Agustı́n Valenzuela-Fernández · 2023 · International Journal of Molecular Sciences
  8. Preparation, Antibacterial and Antiviral Activity Measurements and Detection Methods
    Amol Dilip Gholap, Sagar R. Pardeshi, Prabhanjan Shridhar Giram · 2023 · ACS symposium series
  9. The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription
    Jordan Jennings, Harrison Bracey, Jun Hong, Danny T. Nguyen, Rishav Dasgupta, Alondra Vázquez Rivera, Nicolas Sluis‐Cremer, Jiong Shi, Christopher Aiken · 2024 · PLoS Pathogens
  10. Self-Assembly of Fluorescent HIV Capsid Spheres for Detection of Capsid Binders
    Derrick Lau, James C. Walsh, Amir Mousapasandi, Nicholas Ariotti, Vaibhav B. Shah, Stuart Grant Turville, David A. Jacques, Till Böcking · 2020 · Langmuir
  11. A New Generation of Functional Tagged Proteins for HIV Fluorescence Imaging
    João I. Mamede, Joseph Griffin, Stéphanie Gambut, Thomas J. Hope · 2021 · Viruses
  12. Mapping molecular complexes with super-resolution microscopy and single-particle analysis
    Afonso Mendes, Hannah S. Heil, Simao Coelho, Christophe Leterrier, Ricardo Henriques · 2022 · Open Biology
  13. Computer-aided drug design in seeking viral capsid modulators
    Shujie Zhao, Xujie Zhang, Edeildo Ferreira da Silva‐Júnior, Peng Zhan, Xinyong Liu · 2023 · Drug Discovery Today
  14. Crystal Structure of the Full-Length Feline Immunodeficiency Virus Capsid Protein Shows an N-Terminal β-Hairpin in the Absence of N-Terminal Proline
    Christelle Folio, Natalia Sierra, Marie Dujardin, Guzmán Álvarez, Christophe Guillon · 2017 · Viruses
  15. Virus–Host Interactions in Retrovirus Integration
    Engelman, Alan N., Maertens, Goedele N. · 2018 · Retrovirus-Cell Interactions
  16. A simple, high-throughput stabilization assay to test HIV-1 uncoating inhibitors
    Alžběta Dostálková, Romana Hadravová, Filip Kaufman, Ivana Křížová, Kryštof Škach, Martin Flegel, Richard Hrabal, Tomáš Ruml, Michaela Rumlová · 2019 · Scientific Reports
  17. Tough Way In, Tough Way Out: The Complex Interplay of Host and Viral Factors in Nucleocytoplasmic Trafficking during HIV-1 Infection
    Satarupa Sarkar, Kannan Balakrishnan, Kumaraswami Chintala, Krishnaveni Mohareer, Tom Luedde, Ananda Ayyappan Jaguva Vasudevan, Carsten Münk, Sharmistha Banerjee · 2022 · Viruses
  18. Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators
    Shujing Xu, Lin Sun, Michael J. Barnett, Xujie Zhang, Dang Ding, Anushka Gattu, Dazhou Shi, Jamie R. H. Taka, Wenli Shen, Xiangyi Jiang et al. · 2023 · Journal of Medicinal Chemistry
  19. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions
    Bailey Layish, Ram Goli, Haley Flick, Szu‐Wei Huang, Robert Z. Zhang, Mamuka Kvaratskhelia, Melissa Kane · 2024 · PLoS Pathogens
  20. Fourth generation assays for HIV testing
    Luca Vallefuoco, Claudia Mazzarella, Giuseppe Portella · 2016 · Expert Review of Molecular Diagnostics
  21. RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction
    Kelly M. Marno, Eithne O’Sullivan, Christopher E. Jones, Julieta Díaz-Delfín, Claire Pardieu, Richard D. Sloan, Áine McKnight · 2017 · Journal of Virology
  22. Toward the “unravelling” of HIV: Host cell factors involved in HIV-1 core uncoating
    Daniel J. Rawle, David Harrich · 2018 · PLoS Pathogens
  23. PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles
    Alžběta Dostálková, Kryštof Škach, Filip Kaufman, Ivana Křížová, Romana Hadravová, Martin Flegel, Tomáš Ruml, Richard Hrabal, Michaela Rumlová · 2020 · Molecules
  24. Printed Nanochain‐Based Colorimetric Assay for Quantitative Virus Detection
    Zeying Zhang, Huadong Wang, Meng Su, Yali Sun, Shuang‐Jie Tan, Ekaterina Y. Ponkratova, Maoxiong Zhao, Dongdong Wu, Keyu Wang, Qi Pan et al. · 2021 · Angewandte Chemie
  25. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein
    Shuang Ji, Na Lei, Huiling Ren, Yujie Wang, Xiaojun Wang · 2018 · Journal of Virology
  26. SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
    Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
  27. Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavir
    Derek Hansen, Matthew R. Hendricks, Silvia Chang, Arthur Cai, Jason K. Perry, Thomas Aeschbacher, Ross Martin, Tomáš Cihlář, Stephen R. Yant · 2025 · mBio
  28. People with HIV-1 Demonstrate Type 1 Interferon Refractoriness Associated with Upregulated USP18
    Sho Sugawara, Ramy El–Diwany, Laura K. Cohen, Kimberly E. Rousseau, Christopher Y. K. Williams, Rebecca T. Veenhuis, Shruti H. Mehta, Joel N. Blankson, David L. Thomas, Andrea L. Cox et al. · 2021 · Journal of Virology
  29. Disassembling the Nature of Capsid: Biochemical, Genetic, and Imaging Approaches to Assess HIV-1 Capsid Functions
    Zachary Ingram, Douglas K. Fischer, Zandrea Ambrose · 2021 · Viruses
  30. HIV-1 mutants that escape the cytotoxic T-lymphocytes are defective in viral DNA integration
    Muthukumar Balasubramaniam, Benem-Orom Davids, Alex Bryer, Chaoyi Xu, Santosh Thapa, Jiong Shi, Christopher Aiken, Jui Pandhare, Juan R. Perilla, Chandravanu Dash · 2022 · PNAS Nexus
  31. T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
    Zhiqing Zhang, Maozhou He, Shimeng Bai, Feng Zhang, Jie Jiang, Qingbing Zheng, Shuangquan Gao, Xiaodong Yan, Shaowei Li, Ying Gu et al. · 2018 · Viruses
  32. CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes
    Douglas K. Fischer, Akatsuki Saito, Christopher E. Kline, Romy Cohen, Simon C. Watkins, Masahiro Yamashita, Zandrea Ambrose · 2019 · Journal of Virology
  33. HIV-1 resists MxB inhibition of viral Rev protein
    Zhen Wang, Keli Chai, Qian Liu, Dongrong Yi, Qinghua Pan, Yu Huang, Juan Tan, Wentao Qiao, Fei Guo, Shan Cen et al. · 2020 · Emerging Microbes & Infections
  34. Structure-activity relationship, molecular docking, and molecular dynamic studies of diterpenes from marine natural products with anti-HIV activity
    Natalia Lidmar von Ranke, Mariana Martinelli Junqueira Ribeiro, Leonardo Alves Miceli, Natália Pedroza de Souza, Barbara de Azevedo Abrahim-Vieira, Helena Carla Castro, Valéria Laneuville Teixeira, Carlos Rangel Rodrigues, Alessandra Mendonça Teles de Souza · 2020 · Journal of Biomolecular Structure and Dynamics
  35. Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review
    Usha Rani Kandula, Addisu Dabi Wake · 2022 · Biologics
  36. Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration
    Irena Zurnic, Sylvia Hütter, Ute Rzeha, Nicole Stanke, Juliane Reh, Erik Müllers, Martin V. Hamann, Tobias Kern, Gesche K. Gerresheim, Fabian Lindel et al. · 2016 · PLoS Pathogens
  37. Arg18 Substitutions Reveal the Capacity of the HIV-1 Capsid Protein for Non-Fullerene Assembly
    Randall T. Schirra, Nayara F. B. dos Santos, Barbie K. Ganser‐Pornillos, Owen Pornillos · 2024 · Viruses
  38. Confined no more: Viral mechanisms of nuclear entry and egress
    Freya Molenberghs, Johannes Bogers, Winnok Harald De Vos · 2020 · The International Journal of Biochemistry & Cell Biology
  39. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid
    Dawei Zhang, Rong‐Hua Luo, Lei Xu, Liu‐Meng Yang, Xiaoshuang Xu, Gregory J. Bedwell, Alan Engelman, Yong‐Tang Zheng, Shan Chang · 2019 · Antiviral Research
  40. Structure-based insights into the mechanism of nucleotide import by HIV-1 capsid
    Guang Song · 2019 · Journal of Structural Biology
  41. “Pseudosubstrate Envelope”/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency
    Shujing Xu, Shuo Wang, Yang Zhou, Nicholas Foley, Lin Sun, Laura Walsham, Kai Tang, Dazhou Shi, Xiaoyu Shi, Zhijiao Zhang et al. · 2024 · Journal of Medicinal Chemistry
  42. HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing
    Kaiming Tao, Soo‐Yon Rhee, Philip L. Tzou, Zachary A. Osman, Sergei L. Kosakovsky Pond, Susan Holmes, Robert W. Shafer · 2023 · Viruses
  43. Spatial resolution of HIV-1 post-entry steps in resting CD4 T cells
    Swetha Ananth, Ina Ambiel, Sandra Schifferdecker, Thorsten G. Müller, Paul R. Wratil, Ernesto Mejías‐Pérez, Hans‐Georg Kräusslich, Bárbara Müller, Oliver Till Keppler, O. Fackler · 2024 · Cell Reports
  44. HIV-1 binds dynein directly to hijack microtubule transport machinery
    Somayesadat Badieyan, Drew Lichon, Sevnur Kömürlü Keceli, Michael P. Andreas, John P. Gillies, Wang Peng, Jiong Shi, Morgan E. DeSantis, Christopher Aiken, Till Böcking et al. · 2025 · Science Advances
  45. Review of Current Cell-Penetrating Antibody Developments for HIV-1 Therapy
    Muhamad Che Nordin, Sin‐Yeang Teow · 2018 · Molecules
  46. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors
    Jing Li, Xiangyi Jiang, Alexej Dick, Prem P. Sharma, Chin‐Ho Chen, Brijesh Rathi, Dongwei Kang, Zhao Wang, Xiangkai Ji, Kuo‐Hsiung Lee et al. · 2021 · Bioorganic & Medicinal Chemistry
  47. Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein
    Ivana Křížová, Alžběta Dostálková, Edison Castro, Jan Prchal, Romana Hadravová, Filip Kaufman, Richard Hrabal, Tomáš Ruml, Manuel Llano, Luis A. Echegoyen et al. · 2021 · Viruses
  48. In vitro assembly of the Rous Sarcoma Virus capsid protein into hexamer tubes at physiological temperature
    Soumeya Ali Jaballah, Graham D. Bailey, Ambroise Desfosses, Jaekyung Hyun, ALOK KUMAR MITRA, Richard L. Kingston · 2017 · Scientific Reports
  49. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved
    Théoneste Umumararungu, Jean Baptiste Nyandwi, Jonathan Katandula, Eric Ferdinand Twizeyimana, Jean Claude Didelot Tomani, Noël Gahamanyi, Nestor Ishimwe, Emmanuel Oladayo Olawode, Gratien Habarurema, Matabishi Mpenda et al. · 2024 · Bioorganic & Medicinal Chemistry
  50. CXCR4- and CCR5-Tropic HIV-1 Clones Are Both Tractable to Grow in Rhesus Macaques
    Naoya Doi, Tomoyuki Miura, Hiromi Mori, Hiromi Sakawaki, Takaaki Koma, Akio Adachi, Masako Nomaguchi · 2018 · Frontiers in Microbiology
  51. Biochemical strategies of E3 ubiquitin ligases target viruses in critical diseases
    Ankur Rakesh Dubey, Yuvraj Anandrao Jagtap, Prashant Kumar, Som Mohanlal Patwa, Sumit Kinger, Amit Kumar, Sarika Singh, Amit Prasad, Nihar Ranjan Jana, Amit Mishra · 2021 · Journal of Cellular Biochemistry
  52. Dynactin 1 negatively regulates HIV-1 infection by sequestering the host cofactor CLIP170
    Shanmugapriya Shanmugapriya, Eveline Santos da Silva, Jackson A. Campbell, Marie-Philipe Boisjoli, Mojgan H. Naghavi · 2021 · Proceedings of the National Academy of Sciences
  53. Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
    Shujing Xu, Lin Sun, Waleed A. Zalloum, Tianguang Huang, Xujie Zhang, Dang Ding, Xiaoyu Shao, Xiangyi Jiang, Fabao Zhao, Simon Cocklin et al. · 2022 · Molecules
  54. The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
    Torsten Schaller, Nikolas Herold · 2016 · Current HIV Research
  55. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations
    Philipp Schommers, Glòria Martrus, Urte Matschl, Michael N. Sirignano, Marc Lütgehetmann, Laura E. Richert, Thomas J. Hope, Gerd Fätkenheuer, Marcus A. Altfeld · 2016 · Journal of Virology
  56. Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
    Masayuki Amano, Haydar Bulut, Sadahiro Tamiya, Tomofumi Nakamura, Yasuhiro Koh, Hiroaki Mitsuya · 2019 · Scientific Reports
  57. Help or Hinder: Protein Host Factors That Impact HIV-1 Replication
    Michael Rameen Moezpoor, Mario Stevenson · 2024 · Viruses
  58. Illuminating an invisible state of the HIV-1 capsid protein CTD dimer using 19 F NMR and weighted ensemble simulations
    Darian T. Yang, Lillian T. Chong, Angela M. Gronenborn · 2025 · Proceedings of the National Academy of Sciences
  59. Three-dimensional insights into human enveloped viruses in vitro and in situ
    Naveen Vankadari, Doulin C. Shepherd, Stephen D. Carter, Debnath Ghosal · 2022 · Biochemical Society Transactions
  60. Structure of FIV capsid C-terminal domain demonstrates lentiviral evasion of genetic fragility by coevolved substitutions
    Aya Khwaja, Meytal Galilee, Ailie Marx, Akram Alian · 2016 · Scientific Reports
  61. CPSF6 promotes HIV-1 preintegration complex function
    Evan Chaudhuri, Sooin Jang, Rajasree Chakraborty, Rajalingam Radhakrishnan, Bjarki Arnarson, Prem Prakash, Daphne Cornish, Nicholas Rohlfes, Parmit Kumar Singh, Jiong Shi et al. · 2025 · Journal of Virology
  62. New Advances in Anti-HIV-1 Strategies Targeting the Assembly and Stability of Capsid Protein
    Chengfeng Zhang, Benteng Li, Jiamei Li, Haihong Zhang, Yuqing Wu · 2025 · International Journal of Molecular Sciences
  63. Cationic Residues of the HIV-1 Nucleocapsid Protein Enable DNA Condensation to Maintain Viral Core Particle Stability during Reverse Transcription
    Helena Gien, Michael Morse, Micah J. McCauley, Ioulia F. Rouzina, Robert J. Gorelick, Mark C. Williams · 2024 · Viruses
  64. Keratin-72 restricts HIV-1 infection in resting CD4+ T cells by sequestering capsids in intermediate filaments
    Yang He, Meng Xu, Jiayue Ouyang, Li Zhao, Tian‐Kui Ma, Xiaowei Zhang, Ruolin Wang, Hong Shang, Guoxin Liang · 2025 · Nature Communications
  65. Time-Resolved Fluorescence Imaging and Correlative Cryo-Electron Tomography to Study Structural Changes of the HIV-1 Capsid
    Zaida K. Rodriguez, Jonathan R. Andino-Moncada, Sergey A. Buth, Atousa Mehrani, Ahinsa Ranaweera, Jincheng Shi, Leonardo Rodrigues de Andrade, Satya Prakash Singh, Timothy S. Strutzenberg, Mariana Marin et al. · 2025 · ACS Nano
  66. ReAsH/tetracystein-based correlative light-electron microscopy for HIV-1 imaging during the early stages of infection
    Iryna Lysova, Coralie Spiegelhalter, Éléonore Réal, Sarwat Zgheib, Halina Anton, Yves Mély · 2018 · Methods and Applications in Fluorescence
  67. HIV and the Antiviral Role of Mushroom Nutraceuticals
    Tito Horácio Fernandes, Eusébio Chaquisse, Jorge Ferrão · 2020 · European journal of applied sciences
  68. Uncovering the release mechanism of nucleotide import by HIV-1 capsid
    Guang Song · 2020 · Physical Biology
  69. A Broad-Spectrum Antiviral Molecule, Protoporphyrin IX, Acts as a Moderator of HIV-1 Capsid Assembly by Targeting the Capsid Hexamer
    Dawei Zhang, Liangxu Xie, Xiaoshuang Xu, Yimin Li, Xiaojun Xu · 2022 · Microbiology Spectrum
  70. Quantitative monitoring of the cytoplasmic release of NCp7 proteins from individual HIV-1 viral cores during the early steps of infection
    Sarwat Zgheib, Iryna Lysova, Éléonore Réal, Oleksii Dukhno, Romain Vauchelles, Manuel Pires, Halina Anton, Yves Mély · 2019 · Scientific Reports
  71. Retroviruses
    Wang‐Shick Ryu · 2016 · Elsevier eBooks
  72. CRISPR/Cas9-Induced Mutagenesis Corroborates the Role of Transportin-SR2 in HIV-1 Nuclear Import
    Julie Janssens, Jolien Blokken, Yulia Lampi, Flore De Wit, Irena Zurnic, Iván Nombela, Paulien Van de Velde, Barbara Van Remoortel, Rik Gijsbers, Frauke Christ et al. · 2021 · Microbiology Spectrum
  73. Characterization of two distinct early post-entry blocks to HIV-1 in common marmoset lymphocytes
    Beatriz Pacheco, Luis Menéndez‐Arias, Joseph Sodroski · 2016 · Scientific Reports
  74. The secrets of the stability of the HIV-1 capsid
    Martin Obr, Hans‐Georg Kräusslich · 2018 · eLife
  75. The Confluence of HIV‐1 and HIV‐2: Implications for Disease Progression and Insights for Therapy
    Edwin O. Magomere, Charles Ochieng’ Olwal, Becky Ewurama Tetteh, Mark Appeaning, Thumbi Ndung’u, George B. Kyei, Peter K. Quashie · 2025 · International Journal of Microbiology
  76. Delineating Structural Functionalities of Lenacapavir Amenable to Modifications for Targeting Emerging Drug-Resistant HIV-1 Capsid Variants
    Daniel Adu‐Ampratwum, Arun S. Annamalai, Tung Dinh, Jeffrey R. Lockwood, Ross H. Bockbrader, Reed Haney, Mamuka Kvaratskhelia, James R. Fuchs · 2025 · ACS Medicinal Chemistry Letters
  77. Discovery of Dehydroamino Acid Residues in the Capsid and Matrix Structural Proteins of HIV-1
    Rachel Miller, Rachel A. Knoener, Bayleigh E. Benner, Brian L. Frey, Mark Scalf, Michael R. Shortreed, Nathan M. Sherer, Lloyd M. Smith · 2022 · Journal of Proteome Research
  78. Role of Innate Genes in HIV Replication
    Kerstin Schott, Maximilian Rieß, Renate König · 2017 · Current topics in microbiology and immunology
  79. Nano-Particles Carried by Multiple Dynein Motors Self-Regulate Their Number of Actively Participating Motors
    I. Fayer, G. Halbi, Dina Aranovich, Shachar Gat, Shay Bar, Vitaly Erukhimovitch, Rony Granek, Anne Bernheim‐Groswasser · 2021 · International Journal of Molecular Sciences
  80. Design of reverse transcriptase–specific nucleosides to visualize early steps of HIV-1 replication by click labeling
    Flore De Wit, Sambasiva Rao Pillalamarri, Alba Sebastián-Martín, Akkaladevi Venkatesham, Arthur A. Van Aerschot, Zeger Debyser · 2019 · Journal of Biological Chemistry
  81. DNA Microsystems for Biodiagnosis
    Alana Torres Vidal, Igor L. Medintz, Hieu Bui · 2020 · Micromachines
  82. Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy
    Umesh Chandra Halder · 2018 · Journal of Biological Research - Thessaloniki
  83. Interaction Mechanisms of Cold Atmospheric Plasmas with HIV Capsid Protein by Reactive Molecular Dynamics Simulation
    Ying Fu Sun, Yang Chen, Yuantao T. Zhang · 2024 · Molecules
  84. On board a raft or boat in the retrovirus sea
    Jan Svoboda · 2016 · Proceedings of the National Academy of Sciences
  85. The Retrovirus Capsid Core
    Wei Zhang, Luiza Mendonça, Louis M. Mansky · 2018 · Sub-cellular biochemistry/Subcellular biochemistry
  86. Advances in drug structure-activity-relationships for the development of selenium-based compounds against HIV
    Dazhou Shi, Shujing Xu, Dang Ding, Kai Tang, Yang Zhou, Xiangyi Jiang, Shuo Wang, Xinyong Liu, Peng Zhan · 2023 · Expert Opinion on Drug Discovery
  87. Early HIV replication revisited
    Nathalie Jane Arhel · 2020 · Nature Microbiology
  88. Capsid-dependent lentiviral restrictions
    Joy Twentyman, Michael Emerman, Molly OhAinle · 2024 · Journal of Virology
  89. Two-step recognition of HIV-1 DNA in the cytosol
    Nicholas Dopkins, Douglas F. Nixon · 2022 · Trends in Microbiology
  90. The Interrelationship between HIV Infection and COVID-19: A Review of the Literature
    Yiyu Wang, Yu Lai · 2023 · Current HIV Research
  91. A Branched SELEX Approach Identifies RNA Aptamers That Bind Distinct HIV-1 Capsid Structural Components
    Paige R. Gruenke, Miles D. Mayer, Rachna Aneja, William J. Schulze, Zhenwei Song, Donald H. Burke, Xiao Heng, Margaret J. Lange · 2024 · ACS Infectious Diseases
  92. Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells
    Verena Schlösser, Helen Louise Lightfoot, Christine Leemann, Seyedeh Banijamali, Aathma Merin Bejoy, Shashank Tiwari, Jeffrey L. Schloßhauer, Valentina Vongrad, Andreas Brunschweiger, Jonathan Hall et al. · 2025 · Non-Coding RNA
  93. Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells
    Daphne Cornish, Kathryn A. Jackson-Jones, Ted Ling-Hu, Lacy M. Simons, William J. Cisneros, Edmund Osei Kuffour, Natalie Stegman, Francesca Agnes, Yujin Lee, Ved P. Sharma et al. · 2025 · PLoS Pathogens
  94. JULUCA - a new therapeutic opportunity for patients infected with HIV-1
    Krystian Cholewa, Julita Poleszak, Olga Wysokińska, Adam Gędek, Bartłomiej Zaremba, Przemysław Szabat, Joanna Milanowska · 2019 · World Scientific News
  95. Moloney Murine Leukemia Virus p12 Is Required for Histone Loading onto Retroviral DNAs
    Gary Z. Wang, Stephen P. Goff · 2021 · Journal of Virology
  96. Quinazolinone-based subchemotypes for targeting HIV-1 capsid protein: design and synthesis
    Thamina Akther, William M. McFadden, Huanchun Zhang, Karen A. Kirby, Philip R. Tedbury, Zhengqiang Wang · 2024 · Medicinal Chemistry Research
  97. Effect of internal cleavage site mutations in human immunodeficiency virus type 1 capsid protein on its structure and function
    Ferenc Tóth, János Kádas, János András Mótyán, József Tőzsér · 2016 · FEBS Open Bio
  98. Cellular Factors That Regulate Retrovirus Uncoating and Reverse Transcription
    Stephen P. Goff · 2018 · Elsevier eBooks
  99. Role for Gag-CA Interdomain Linker in Primate Lentiviral Replication
    Naoya Doi, Takaaki Koma, Akio Adachi, Masako Nomaguchi · 2019 · Frontiers in Microbiology
  100. The Quest for the Blueprint of the Nuclear Pore Complex
    Joseph S. Glavy · 2019 · The Protein Journal